Neurotoxins
What Are Neurotoxins?
Neurotoxins are a category of poisonous substances showing adverse or destructive influences on the nervous system. A wide range of neurotoxic molecules, natural or synthetic and endogenous or exogenous, have been identified since the first discovery of botulinum toxins in 1822. Common neurotoxins here list include natural bacterial exotoxins, synthetic pesticides, endogenous nitric oxide and glutamate, exogenous ethanol and some psychoactive drugs, and so forth. These neurotoxins, through acting on specific parts of neurons, interfere with the cellular pathways and biological processes of normal neurons and affect the interaction of neurons and the transmission of neural signals, thereby causing abnormalities or diseases of the nervous system.
However, although the neurotoxins are destructive and toxic to the nervous system, the capability of specifically target neural tissues and neurons provides great potential to neuroscientific research. Currently, neurotoxins play a critical role in animal modeling of neurological diseases for pathological mechanism exploration. More importantly, multiple neurotoxin drugs have been developed for the treatment of a series of neurological disorders.
Fig.1 Neurotoxins in animal modeling of Parkinson’s disease. (Prasad, 2020)
Neurotoxin Applications
Applications in research: Most neurotoxins are selective and destructive to the central neural system that specifically targets neural tissues or neurons. So far, an array of selective neurotoxins have been identified, which selectively inactivate one phenotypic nerve, one channel, or one pathway, while retaining other neural activities. This characteristic of neurotoxin makes them powerful tools in neurological disease modeling and neuroscience studies.
Applications in therapeutics: Using neurotoxins for neurological disease treatment originated botulinum toxins, secretory proteins of bacterium Clostridium botulinum. Now several botulinum neurotoxin drugs have been approved for the treatment of migraine, restricted ankle motion, bladder hyperactivity, pediatric lower limb spasticity, and other off-label indications.
Neurotoxin Types Based on Mechanisms
Numbers of neurotoxins have been discovered and identified at present. The neurotoxic mechanisms of these neurotoxins vary, but they usually exert neurotoxicity by different inhibiting neural processes. Current reported functional mechanisms mainly include:
- interfering with the activity of ion channels on the cell membrane of neurons;
- acting on synapses to inhibit the transmission of neurotransmitters;
- affecting the permeability of the blood-brain barrier;
- acting on the surface receptor of neurons to interfere with intracellular signaling pathways
Therefore, neurotoxins are generally classified into several subgroups as follows (classification and typical examples) according to their different neurotoxic mechanisms.
- Na+ channel inhibitors: Tetrodotoxin
- K+ channel inhibitors: Tetraethylammonium
- Cl- channel inhibitors: Chlorotoxin
- Ca2+ channel inhibitors: Conotoxin
- Synaptic vesicle release inhibitors: Botulinum and Tetanus Toxins
- Blood-brain barrier inhibitors: mercury
- Receptor agonists: 25I-NBOMe, JWH-018, and 5-MEO-DiPT
- Receptor antagonists: Bungarotoxin and Curare
- Excitatory neurotoxin: α-Latrotoxin
Fig.2 Sites of action of snake neurotoxins and other substances on the neuromuscular junction. (Ranawaka, 2013)
Creative Biolabs now provides a comprehensive range of neural products and tailored services for neuroscience research. Please directly contact us for detailed information if you are interested or have any questions.
References
- Prasad, E.M.; et al. Behavioral Tests in Neurotoxin-Induced Animal Models of Parkinson's Disease. Antioxidants (Basel, Switzerland). 2020, 9(10): 1007.
- Ranawaka, U.K.; et al. Neurotoxicity in Snakebite-The Limits of Our Knowledge. PLoS Neglected Tropical Diseases. 2013, 7(10): e2302.
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2275) (Cat#: NRP-0422-P2275)
- iNeuMab™ Anti-Alpha Synuclein Antibody (NRP-0422-P614) (Cat#: NRP-0422-P614)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1686) (Cat#: NRP-0422-P1686)
- iNeuMab™ Anti-TREM2 Antibody (NRP-0422-P792) (Cat#: NRP-0422-P792)
- iNeuMab™ Anti-ApoC3 BBB Shuttle Antibody (NRZP-1022-ZP3505) (Cat#: NRZP-1022-ZP3505)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- Mouse Microglia Cell Line BV-2, Immortalized (Cat#: NCL2110P153)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- Mouse Microglia N9 (Cat#: NCL2110P073)
- Rat Immortalized Retinal Muller Cell Line rMC-1 (Cat#: NCL-2106-S93)
- Human Brain Microvascular Endothelial Cells (Cat#: NCL-2103-P133)
- Mouse Microglia from C57BL/6 (Cat#: NCL-21P6-082)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Rat Muller Cell (Cat#: NCL2110P040)
- Rat Schwann Cells RSC96, Immortalized (Cat#: NCL-2108P21)
- Mouse Midbrain Dopaminergic Neuron Cell MN9D (Cat#: NCL2110P059)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP509)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-IDS BBB Shuttle Protein (Cat#: NRZP-0423-ZP503)